Previous 10 | Next 10 |
Boca Raton, FL, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases today announced it has entered into an ...
OTC listed Connectyx Technologies ([[CTYX]] +24.1%) has agreed to acquire worldwide rights for IMT504, an immunotherapy, to treat symptomatic rabies, from Mid-Atlantic BioTherapeutics."Our goal is to be in the clinic by Q1 2022. As a result of the near 100% fatality rate in late-sta...
Boca Raton, FL, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases, announced today the Com...
Company to Acquire Worldwide Rights for Development of IMT504 Boca Raton, FL, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focu...
Boca Raton, FL, July 06, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases today announced it is in licensing...
Boca Raton, FL, May 08, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a global biomedical company that focuses on the orphan drug space announced today that Michael Grace, Ph.D. and Rona...
BOCA RATON, FL, May 01, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC PINK: CTYX), a global biomedical company issues the following update to shareholders. Dear fellow shareholders and interested investors: Based on the volume of e-mails received re...
More than $350,000 of Convertible Debt Eliminated BOCA RATON, FL, April 13, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group (OTC PINK: CTYX) has filed all required annual reports from 2014 through 2019 to become current with its OTC Markets filing requirements. ht...
BOCA RATON, FL, March 06, 2020 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group (OTC PINK: CTYX) issued a shareholder update today regarding recent corporate developments including management and Board of Director changes. SunMed Advisors, LLC has recently acquired ma...
Connectyx Technologies, Corp. requests that their press release NewsItemId: 20200206005108 “Connectyx Receives a 7 Million USD Funding Commitment From a Chinese Institution for Personal Early Response System Software (PERS)” be killed. The release was issued without authoriz...
News, Short Squeeze, Breakout and More Instantly...
Curative Biotechnology Inc Company Name:
CTYX Stock Symbol:
OTCMKTS Market:
Boca Raton, FL, May 25, 2021 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company targeting novel treatments for rare diseases, filed its Q1 quarterly report for the period...
Biotechnology Company Issues Highlights and Subsequent Events Boca Raton, Fla, March 09, 2021 (GLOBE NEWSWIRE) -- Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on ...
Connectyx Announces Key Biotech Industry Veterans to Management Team Expertise in Clinical Development, Regulatory Affairs and Manufacturing Represented PR Newswire BOCA RATON, Fla. , Feb. 11, 2021 /PRNewswire/ -- Connectyx Technologies Holdings Group, I...